Biochemical parameters, histological features and sleep characteristics of patients with non-alcoholic fatty liver disease (NAFLD) and controls.

NAFLD Patients (n = 46; simple steatosis n = 12, Non-alcoholic steatohepatitis [NASH] n = 34) and controls n = 22.‡, significant difference Controls vs. Steatosis§, significant difference Controls vs. NASHHomeostasis model assessment of insulin resistance (HOMA-IR). NAFLD activity score (NAS). Hours (h). Minutes (min.). Munich Chronotype Questionnaire (MCTQ). Pittsburgh Sleep Quality Index (PSQI); a score ≤ 5 is considered good sleep quality. Positive and negative affect scale (PANAS). Epworth Sleepiness scale (ESS); a score Biochemical parameters, histological features and sleep characteristics of patients with non-alcoholic fatty liver disease (NAFLD) and controls.